Proteins and Peptides

06 Mar 2007 InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
03 Mar 2007 GTC Biotherapeutics Enters Into Process Development And Clinical Supply Manufacturing Services Agreement With Pharmathene For Protexia
02 Mar 2007 Biolex Therapeutics Researchers Present Preclinical Data for Direct-Acting Thrombolytic BLX-155 at Scientific Conference
02 Mar 2007 Levemir(R) approved in Europe for use in combination with oral antidiabetic drugs
02 Mar 2007 Results with New Integrase Inhibitor Plus FUZEON and Boosted Protease Inhibitor Show Remarkable Undetectable Rate of 98 Percent in Treatment-Experienced HIV Patients
02 Mar 2007 Kamada begins phase III clinical trial in the U.S. with its Alpha-1 Antitrypsin product indicated for Congenital Emphysema
28 Feb 2007 Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
28 Feb 2007 Nautilus Biotech announces IND filing for Belerofon, its oral, long-lasting, Interferon-alpha drug
28 Feb 2007 Jerini Plans to Submit US New Drug Application in Third Quarter 2007 for Icatibant in Hereditary Angioedema
28 Feb 2007 Human Genome Sciences Announces Positive Interim Results Of Phase 2B Trial Of Albuferon(R) With Ribavirin In Treatment-Naïve Patients With Chronic Hepatitis C
28 Feb 2007 Human Genome Sciences Initiates Phase 3 Clinical Trial Of Albuferon(R) With Ribavirin In Treatment-Naïve Patients With Chronic Hepatitis C Genotypes 2 And 3
27 Feb 2007 Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
27 Feb 2007 Phase 3 stroke trial shows that NovoSeven® reduces bleeding in the brain, but does not improve long-term clinical outcomes
27 Feb 2007 Lilly Plans New Clinical Trial of Xigris
27 Feb 2007 Ipsen Grants Galderma Exclusive Rights to Develop, Promote and Distribute Its Botulinum Toxin Type A Product for Aesthetic Indications in Europe and Certain Other Territories
26 Feb 2007 TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln
24 Feb 2007 Recruitment temporarily suspended into C.E.R.A. Phase II oncology trial
22 Feb 2007 Breakthrough oral delivery for arthritis sufferers
22 Feb 2007 BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
22 Feb 2007 Allon files IND for approval of Schizophrenia Phase II clinical trials
21 Feb 2007 Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
21 Feb 2007 Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
21 Feb 2007 Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE
17 Feb 2007 OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
16 Feb 2007 Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up